Shares of Jazz Pharmaceuticals (JAZZ: Quote) rose sharply during the first hour of trade Monday, but settled into a range for the remainder of the day. The stock closed up by 7.17 at $55.29, with volume at a 4 1/2 month high.
Jazz Pharmaceuticals surged past resistance Monday and set a new high for the year. The company reportedly received a positive ruling from its Xyrem patent lawsuit against Roxane Laboratories.
Click here to receive FREE breaking news email alerts for Jazz Pharmaceuticals plc and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org